Arsanis, Inc. (NASDAQ:ASNS) major shareholder Polaris Venture Management Co. acquired 500,000 shares of the company’s stock in a transaction that occurred on Monday, November 20th. The shares were bought at an average cost of $10.00 per share, for a total transaction of $5,000,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Shares of Arsanis, Inc. (NASDAQ ASNS) traded up $0.35 on Thursday, reaching $13.50. The company had a trading volume of 44,727 shares, compared to its average volume of 37,286. Arsanis, Inc. has a twelve month low of $12.33 and a twelve month high of $19.73.
ILLEGAL ACTIVITY NOTICE: “Insider Buying: Arsanis, Inc. (NASDAQ:ASNS) Major Shareholder Purchases 500,000 Shares of Stock” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/12/07/polaris-venture-management-co-acquires-500000-shares-of-arsanis-inc-asns-stock.html.
Arsanis, Inc is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company’s mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500.
Receive News & Ratings for Arsanis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arsanis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.